AMERICAN SHARED HOSPITAL SERVICES Capital Expenditures Incurred but Not yet Paid
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Capital Expenditures Incurred but Not yet Paid of $400.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $400.00K, a 81.48% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$400.00K, a 115.44% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for fiscal 2025 was $400.00K, a 59.60% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for fiscal 2024 was $990.00K, a 49.36% decline from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for fiscal 2023 was $1.96M.
- AMERICAN SHARED HOSPITAL SERVICES capital expenditures incurred but not yet paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $400.00K 10-Q · filed 2026-08-13 | $400.00K derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-14 | $400.00K derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | -$1.36M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | -$400.00K derived: sum of 2 quarters · filed 2026-03-31 | -$1.76M derived: sum of 3 quarters · filed 2026-08-13 | $400.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$400.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | -$1.76M derived: sum of 2 quarters · filed 2026-08-13 | $400.00K 10-Q/A · filed 2026-01-16 | -$1.72M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $800.00K 10-Q · filed 2026-08-13 | -$1.32M derived: sum of 3 quarters · filed 2026-08-13 | $1.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.16M 10-Q · filed 2026-05-14 | $36.00K derived: sum of 2 quarters · filed 2026-05-14 | $2.63M derived: sum of 3 quarters · filed 2026-05-14 | $1.98M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$2.12M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $466.00K derived: sum of 2 quarters · filed 2026-03-31 | -$184.00K derived: sum of 3 quarters · filed 2026-03-31 | $990.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $2.59M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | $1.94M derived: sum of 2 quarters · filed 2026-01-16 | $3.11M 10-Q/A · filed 2026-01-16 | $5.07M derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | -$650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $524.00K 10-Q · filed 2025-08-13 | $2.48M derived: sum of 3 quarters · filed 2025-08-13 | $2.48M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.17M 10-Q · filed 2025-05-15 | $3.13M derived: sum of 2 quarters · filed 2025-05-15 | $3.13M derived: sum of 3 quarters · filed 2025-05-15 | $3.13M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $1.96M derived: sum of 2 quarters · filed 2025-04-04 | $1.96M derived: sum of 3 quarters · filed 2025-04-04 | $1.96M 10-K · filed 2025-04-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $1.10M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.10M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $1.10M 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $1.18M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.18M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.18M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |